By Ahmed El-Medany Presented by Professor Michele Brignole, San Luca Hospital, Milan, APAF-CRT was a two-phase trial in individuals with severely symptomatic atrial fibrillation (AF)…
View More Highlights from Day 2 of the ESC 2021 congress – APAF-CRT
The ENVISAGE-TAVI AF trial demonstrated that Edoxaban’s non-inferiority to warfarin with regards to myocardial infarction (MI), ischaemic stroke, systemic thromboembolism, and valve thrombosis, in participants…
View More Highlights from Day 2 of the ESC 2021 congress – ENVISAGE-TAVI AF
Presented by Dr. Marco Valgimigli, the MASTER DAPT trial assessed whether 1 month of dual antiplatelet therapy (DAPT) following percutaneous coronary intervention (PCI), with a…
View More Highlights from Day 2 of the ESC 2021 congress – MASTER DAPT
By Ahmed El-Medany As usual, there were a multitude of fascinating trials presented at the Hot Line session at the ESC Congress 2021. Professor Axel…
View More Highlights from Day 1 of the ESC congress – SMART-MI
In 2020, new clinical practice guidelines were published by the European Society of Cardiology. The BCS Clinical Standards Group has reviewed the guidelines and written…
View More BCS Review of ESC Clinical Practice Guidelines: 2020